JAN Company Profile and Key Details

Janus Living, Inc. (NYSE:JAN) closed at $25.72 USD, losing -$0.42 (-1.61%) from the previous close of $26.14. The stock is currently within 5% of its 52-week high $22.76 and $26.70. With a market capitalization of about $224.13 million, Janus Living, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~2.16). Key stats such as the average daily volume over the past year has been around 2.30 million shares, volume is running light vs its 52-week average. Headquartered in Las Vegas, NV, Janus Living, Inc. operates in the Industrials sector and the Waste Management industry. Led by CEO Scott Brinker, the company employs approximately 5 people and listed since March 20, 2026. JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction.

JAN has shown mixed momentum, gaining 6.19% over the past week and -26.16% over the past quarter, though year-to-date performance is up 301.8%. Short-term trend indicators are mixed aligned (SMA20 2.13%, SMA50 -22.69%, SMA200 35.88%). The stock’s 14-day RSI is 44.39 (neutral), while the ATR of 0.27 points to moderate volatility. The stock remains hovering near 52-week lows, trading -57.6% below its high and over 911.8% above its low. Average 10-day trading volume of 777.95 thousand shares is below the 3-month average of 1.17 million, indicating normal recent market interest.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Janus Living, Inc. generated EPS of -$3.23 over the past year. Five-year average earnings growth is 23.21%. Analyst sentiment is bullish. Analyst rating data shows there are 8 Strong Buy ratings, 0 Buy ratings, 1 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $28.00 to $26.00. The high target offers 8.74% upside. The low target suggests 0.97% downside. The mean target is $27.00. This offers 4.85% upside.

Janus Living, Inc. has 12.17 million shares outstanding. The public float is 8.74 million shares, elevated short interest at 1.37% of float. This equals 164.99 thousand shares. The short ratio is 1.28 days. Institutional investors hold 5.37% of the float. Insiders own 0.92%. MEDALLION CAPITAL INC holds 492.00 thousand shares, BEDNARCZYK W WILLIAM has 200.00 thousand shares and Isaac Capital Group, LLC has 110.12 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Our AI price prediction model suggests that Janus Living, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -0.89%, with price expected at $25.52 by April 28, 2026, within a range of $24.90 to $26.15 3-Month Outlook: Projected fall of -40.0%, reaching $15.45 by July 13, 2026, with a range of $14.69 to $15.96. 1-Year Outlook: Projected loss of -6.33%, with price at $24.12 by April 14, 2027, within a range of $22.68 to $25.11.

Janus Living, Inc. (NYSE:JAN) shares are up 301.8% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Analyst sentiment is mixed, with the majority of ratings in Neutral territory and a mean price target of $27.00, suggesting 4.85% upside. Our AI forecast model points to short-term weakness (-0.89% over two weeks), a medium-term fall (-40.0% over three months), and a longer-term loss (-6.33% over one year), with expected trading ranges indicating moderate volatility.